Natural IVF cycles may be desirable for women with repeated failures by stimulated IVF cycles

Journal of Assisted Reproduction and Genetics

Volumn 25, Issue 4, 2008, Pages 163-167

  Matsuura, Toshiki ^a,c   Takehara, Yuji ^a   Kaijima, Hirotsune ^a   Teramoto, Shokichi ^b   Kato, Osamu ^a,b  

^a Kato Ladies Clinic   (Japan)

^b Shinbashi Yume Clinic   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced age; GnRH agonist; LH surge; Natural IVF cycle; Stimulated IVF cycle

Indexed keywords

BUSERELIN ACETATE; GONADORELIN; LUTEINIZING HORMONE;

ARTICLE; CASE REPORT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE RELEASE; MATERNAL AGE; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OVARY FOLLICLE; PREGNANCY; PRIORITY JOURNAL;

ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; MALE; OVULATION INDUCTION; PREGNANCY; TREATMENT FAILURE;

EID: 42549162039     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-008-9204-7     Document Type: Article

References (19)

1. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978;7:366.
2. Lim JH, Yang SH, Chian RC. New alternative to infertility treatment for women without ovarian stimulation. Reprod Biomed Online 2007;14:547-9.
3. Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age. A prospective randomized controlled trial. Hum Reprod 2004;19:2849-58.
4. Teramoto S, Kato O. Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study. Reprod Biomed Online 2007;15:134-48.
5. Strauss JF, Barbieri RL. Yen and Jaffe's reproductive endocrinology. Philadelphia, PA: Saunders; 2004.
6. Humaidan P, Bredkjær HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005;20:1213-20.
7. Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey A, Diedrich K, et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 2005;20:2887-92.
8. Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 1990;71:918-22.
9. Damewood MD, Shen W, Zacur HA, Schlaff WD, Rock JA, Wallach EE. Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril 1989;52:398-400.
10. Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 2002;87:709-15.
11. Trokoudes KM, Minbattiwalla MB, Kalogirou L, Pantelides K, Mitsingas P, Sokratous A, et al. Controlled natural cycle IVF with antagonist use and blastocyst transfer. Reprod Biomed Online 2005;11:685-9.
12. Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Updat 2002;8:129-39.
13. Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod 2001;16:259-62.
14. Center for Disease Control and Prevention 2006 Assisted reproductive technology (ART) CDC Atlanta, GA http://www.cdc.gov/ART/ART2004/ Center for Disease Control and Prevention. Assisted reproductive technology (ART). Atlanta, GA: CDC; 2006. http://www.cdc.gov/ART/ART2004/.
15. Andersen AN, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG. The European IVF-monitoring programme (EIM), European Society of Human Reproduction and Embryology (ESHRE): Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod 2005;20:1158-76.
16. Elizur SE, Lerner-Geva L, Levron J, Shulman A, Bider D, Dor J. Cumulative live birth rate following in vitro fertilization: study of 5,310 cycles. Gynecol Endocrinol 2006;22:25-30.
17. Lintsen AM, Eijkemans MJ, Hunault CC, Bouwmans CA, Hakkaart L, Habbema JD, et al. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod 2007;22:2455-62.
18. Munne S, Magli C, Adler A, Wright G, de Boer K, Mortimer D, et al. Treatment-related chromosome abnormalities in human embryos. Hum Reprod 1997;12:780-4.
19. Edwards RG. IVF, IVM, natural cycle IVF, minimal stimulation IVF-time for a rethink. Reprod Biomed Online 2007;15:106-19.